Barclay Damon is pleased to announce that Franklin Abrams has joined the firm as special counsel in the Patents & Prosecution, Intellectual Property Litigation, and Trademarks, Copyrights & Licensing Practice Areas, strengthening the firm’s Intellectual Property Practice Group and underscoring the firm’s continued investment in sophisticated patent and technology-driven practices that support innovative companies at every stage of growth. Abrams will practice out of Barclay Damon’s Albany and New York City offices
Abrams is a patent attorney with more than 20 years of experience advising clients across the life sciences, pharmaceuticals, medical devices, and chemical sectors. His practice spans patent preparation and prosecution; patent portfolio development and management; strategic intellectual property counseling; and drafting opinions relating to patentability, validity, enforceability, non-infringement, freedom-to-operate, and Hatch-Waxman Paragraph IV certifications. Holding a PhD in molecular biology and biochemistry, he brings deep technical insight to matters involving pharmaceuticals, biotechnology, medical devices, synthetic biology, biomaterials, antibodies, agricultural sciences, and industrial chemistry as well as significant experience with.
“Barclay Damon’s strength in serving innovative companies aligns well with my background in life sciences and chemistry, and I look forward to helping clients build, protect, and leverage their IP portfolios,” said Abrams.
Before joining Barclay Damon, Abrams served in both private practice and in-house roles, including as intellectual property counsel for a medical device pharmaceutical company and as foreign IP counsel at a leading firm in Beijing.
Denis Sullivan, co-leader of Barclay Damon’s Intellectual Property Practice Group, said, “Franklin brings a rare combination of deep scientific training and decades of practical patent experience.” John Cook, co-leader of Barclay Damon’s Intellectual Property Practice Group, continued, “His ability to align complex technology with business strategy will be an immediate asset to our clients and our IP team.”
Lizz Acee, managing director of Barclay Damon’s major market offices, said, “Franklin’s addition to our Albany office and recently expanded New York City office strengthens our ability to serve clients with highly sophisticated technologies. He adds meaningful depth to our patent prosecution and litigation capabilities.”
Barclay Damon attorneys team across offices and practices to provide customized, targeted solutions grounded in industry knowledge and a deep understanding of our clients' businesses. With approximately 300 attorneys, Barclay Damon is a leading regional law firm that operates from a strategic platform of offices in Albany, Boston, Buffalo, New Haven, New York City, Rochester, Syracuse, Washington DC, and Toronto. Our firm serves clients across the country and, for some practices, provides US legal services around the globe. For more information, visit our award-winning website at barclaydamon.com.